#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5057963	B	Inhibition of human BCL6 (5 to 129 residues) expressed in Escherichia coli BL21-AI using BCOR-AF633 peptide as substrate measured after 2 hrs by TR-FRET assay	Homo sapiens	28	ALA5055684	assay format	Scientific Literature
2.	ALA5057964	P	Solubility of the compound in HEPES buffer incubated for 20 hrs by quantitative - 1H-NMR analysis		18	ALA5055684	small-molecule physicochemical format	Scientific Literature
3.	ALA5057966	A	Permeability of the compound by PAMPA		12	ALA5055684	assay format	Scientific Literature
4.	ALA5057967	B	Inhibition of human nanoLuc-tagged BCL6 expressed in HEK293T cells coexpressing HaloTag-SMRT using NanoBRET furimazine substrate incubated for 6 hrs by NanoBRET assay	Homo sapiens	8	ALA5055684	cell-based format	Scientific Literature
5.	ALA5057968	B	Binding affinity to human BCL6 BDB domain by SPR assay	Homo sapiens	1	ALA5055684	single protein format	Scientific Literature
6.	ALA5057969	F	Antiproliferative activity against BCL-6 positive human OCI-Ly1 cells assessed as growth inhibition incubated for 14 days by CellTiter Glo assay	Homo sapiens	1	ALA5055684	cell-based format	Scientific Literature
7.	ALA5057970	F	Antiproliferative activity against BCL-6 positive human SU-DHL-4 cells assessed as growth inhibition incubated for 14 days by CellTiter Glo assay	Homo sapiens	1	ALA5055684	cell-based format	Scientific Literature
8.	ALA5057971	F	Antiproliferative activity against BCL-6 positive human SU-DHL-6 cells assessed as growth inhibition incubated for 14 days by CellTiter Glo assay	Homo sapiens	1	ALA5055684	cell-based format	Scientific Literature
9.	ALA5057972	F	Antiproliferative activity against BCL-6 low human OCILY3 cells assessed as growth inhibition incubated for 14 days by CellTiter Glo assay	Homo sapiens	1	ALA5055684	cell-based format	Scientific Literature
10.	ALA5057973	F	Antiproliferative activity against BCL-6 low human MM.1S cells assessed as growth inhibition incubated for 14 days by CellTiter Glo assay	Homo sapiens	1	ALA5055684	cell-based format	Scientific Literature
11.	ALA5057974	T	Toxicity in BALB/c mouse at 1 mg/kg, iv or 5 mg/kg, po	Mus musculus	1	ALA5055684	organism-based format	Scientific Literature
12.	ALA5057975	A	Clearance in BALB/c mouse at 1 mg/kg, iv or 5 mg/kg, po	Mus musculus	1	ALA5055684	organism-based format	Scientific Literature
13.	ALA5057976	A	Oral bioavailability in BALB/c mouse at 5 mg/kg	Mus musculus	1	ALA5055684	organism-based format	Scientific Literature
14.	ALA5057977	A	Plasma concentration in BALB/c mouse assessed as unbound fraction at 1 mg/kg, iv or 5 mg/kg, po	Mus musculus	1	ALA5055684	organism-based format	Scientific Literature
15.	ALA5057978	B	Inhibition of BCOR peptide binding to human BCL6 expressed in Escherichia coli measured after 270 mins by BCOR ULight TR-FRET assay	Homo sapiens	2	ALA5055684	assay format	Scientific Literature
16.	ALA5057979	P	Lipophilicity, logD of the compound at pH 7.4		3	ALA5055684	small-molecule physicochemical format	Scientific Literature
17.	ALA5136200	P	Kinetic aqueous solubility of the compound in pH 7.4 in 1% DMSO/PBS buffer measured after 2 hrs by HPLC-UV analysis		7	ALA5131540	small-molecule physicochemical format	Scientific Literature
18.	ALA5136201	B	Inhibition of human C-terminal nanoLuc-tagged BCL6 expressed in HEK293T cells co-expressing HaloTagged-SMRT using NanoBRET furimazine as substrate incubated for 6 hrs by NanoBRET assay	Homo sapiens	12	ALA5131540	cell-based format	Scientific Literature
19.	ALA5136202	B	Inhibition of human N-terminal thioredoxin 6-His tagged BCL6 BTB domain (5 to 129 residues) expressed in Escherichia coli BL21-AI using BCOR-AF633 peptide as substrate incubated for 2 hrs by TR-FRET assay	Homo sapiens	24	ALA5131540	assay format	Scientific Literature
20.	ALA5136203	F	Antiproliferative activity against human OCI-Ly1 cells assessed as cell growth inhibition mesured after 14 days by CellTiter-Glo luminescent assay	Homo sapiens	2	ALA5131540	cell-based format	Scientific Literature